Jeremy A. Bartlett - Concepedia

Author

Jeremy A. Bartlett

Pfizer (United States)

Also Known As

Jeremy A. Bartlett, Jeremy Bartlett, Malinoski, Frank

Publications

535

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of Wisconsin–Madison

About

Jeremy A. Bartlett is an author at Pfizer (United States) specializing in medicine, photochemistry, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	194
2	Health Sciences	3	3	177
3	Engineering	2	2	92
4	Arts	1	1	64
5	Natural Sciences	1	1	30

Jeremy A. Bartlett

Publications

433

Citations

H-Index

Page 1

	Year	Citations
Effect of Molecular Structure on the Performance of Triarylmethane Dyes as Therapeutic Agents for Photochemical Purging of Autologous Bone Marrow Grafts from Residual Tumor Cells Guilherme L. Indig, Gregory S. Andérson, Michael G. Nichols, Journal of Pharmaceutical Sciences PhotochemistryPhotodynamic TherapyTriarylmethane DyesPhototoxicitySynthetic Photochemistry	2000	77
Effect of molecular structure on the selective phototoxicity of triarylmethane dyes towards tumor cells Irawati Kandela, Jeremy A. Bartlett, Guilherme L. Indig Photochemical & Photobiological Sciences EngineeringPhotochemistryPhotodynamic TherapyPhototoxicityOrganic Chemistry	2002	76
Understanding the Oral Mucosal Absorption and Resulting Clinical Pharmacokinetics of Asenapine Jeremy A. Bartlett, Kees van der Voort Maarschalk AAPS PharmSciTech Pharmacological StudyMedicineOral Mucosal AbsorptionResulting Clinical PharmacokineticsDrug Absorption	2012	64
Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop Robert L. Ternik, Fang Liu, Jeremy A. Bartlett, International Journal of Pharmaceutics Pediatric FeedingPediatric SwallowingOral CavityPediatricsPediatric Lung Disease	2017	64
Effect of Self‐association and Protein Binding on the Photochemical Reactivity of Triarylmethanes. Implications of Noncovalent Interactions on the Competition between Photosensitization Mechanisms Type I and Type II Jeremy A. Bartlett, Guilherme L. Indig Photochemistry and Photobiology	1999	33
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity Richard L. Elliott, Kimberly O. Cameron, Janice E. Chin, Bioorganic & Medicinal Chemistry Letters Metabolic SyndromeMedicinal ChemistryBiochemistryFunctional SelectivityMedicine	2010	30
Summary Report of PQRI Workshop on Nanomaterial in Drug Products: Current Experience and Management of Potential Risks Jeremy A. Bartlett, Marcus E. Brewster, Paul C. Brown, The AAPS Journal	2014	25
Spectroscopic and photochemical properties of Malachite Green noncovalently bound to bovine serum albumin Jeremy A. Bartlett, Guilherme L. Indig Dyes and Pigments Food ChemistrySerum AlbuminBiochemistryPhotochemistryPhotochemical Properties	1999	24
Monitoring microsphere coating processes using PAT tools in a bench scale fluid bed Barbara Santos Silva, Marie-Josée Colbert, M. M. M. Santangelo, European Journal of Pharmaceutical Sciences Materials ScienceEngineeringMicrofabricationMechanical EngineeringSurface Science	2019	16
Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide Ralph P. Robinson, Jeremy A. Bartlett, Peter Bertinato, Bioorganic & Medicinal Chemistry Letters Metabolic SyndromeBiochemistryMedicineMetabolomic ProfilingPharmacotherapy	2011	12

Page 1